{"id":218,"date":"2023-08-02T07:23:00","date_gmt":"2023-08-02T07:23:00","guid":{"rendered":"https:\/\/doctorflaviaharadja.ro\/?p=218"},"modified":"2023-08-02T07:23:00","modified_gmt":"2023-08-02T07:23:00","slug":"menopauza-precoce-cauze-genetice","status":"publish","type":"post","link":"https:\/\/doctorflaviaharadja.ro\/en\/menopauza-precoce-cauze-genetice\/","title":{"rendered":"Menopauza precoce \u2013 cauze genetice"},"content":{"rendered":"<p>Hipogonadismul primar la femei este definit ca insuficien\u021b\u0103 ovarian\u0103 \u00eenso\u021bit\u0103 de concentra\u021bii serice ridicate de hormon foliculostimulator (FSH). Insuficien\u021ba ovarian\u0103 prematur\u0103 (POF), denumit\u0103 \u00een prezent insuficien\u021b\u0103 ovarian\u0103 primar\u0103 (POI), este definit\u0103 ca hipogonadism primar la o femeie cu v\u00e2rsta sub 40 de ani.<\/p>\n<p>POI se caracterizeaz\u0103 prin pierderea de ovocite, lipsa foliculogenezei \u0219i a produc\u021biei de estrogen ovarian \u0219i infertilitate. Reluarea tranzitorie sau par\u021bial\u0103 a activit\u0103\u021bii ovariene a fost documentat\u0103 la peste 50 la sut\u0103 dintre femeile cu POI pe baza m\u0103sur\u0103torilor hormonale, a ecografiei pelvine sau a concep\u021biei.<\/p>\n<p>Exist\u0103 mai multe cauze cunoscute ale insuficien\u021bei ovariene, inclusiv defecte cromozomiale, cum ar fi sindromul Turner \u0219i purt\u0103torii de premuta\u021bii ale sindromului X fragil, expunerea la radia\u021bii \u0219i la anumite medicamente \u0219i boli autoimune. Lista muta\u021biilor care pot cauza insuficien\u021ba ovarian\u0103 a crescut rapid, pe m\u0103sur\u0103 ce descoperirile din cadrul proiectului genomului uman \u0219i secven\u021bierea NGS ne sporesc \u00een\u021belegerea factorilor implica\u021bi \u00een dezvoltarea ovarelor. Din nefericire, etiologia r\u0103m\u00e2ne necunoscut\u0103 \u00een aproximativ 75 p\u00e2n\u0103 la 90 la sut\u0103 din cazuri.<\/p>\n<p>PATOGENEZ\u0102<\/p>\n<p>Dezvoltarea normal\u0103 a ovarelor depinde de o cascad\u0103 de evenimente atent cronometrate; ca urmare, exist\u0103 multiple etiologii poten\u021biale pentru disfunc\u021bia ovarian\u0103. Din punct de vedere fiziopatologic, aceste defecte pot fi \u00eemp\u0103r\u021bite \u00een dou\u0103 categorii majore:<\/p>\n<ul>\n<li>Epuizarea accelerat\u0103 a foliculilor<\/li>\n<li>Diminuarea produc\u021biei de steroizi f\u0103r\u0103 pierdere de ovocite<\/li>\n<\/ul>\n<p>Alte cauze teoretice ale insuficien\u021bei ovariene, inclusiv absenta migrarii a celulelor germinale sau dezvoltarea ovarian\u0103 defectuoas\u0103, nu au fost \u00eenc\u0103 descrise, de\u0219i unele gene par s\u0103 joace un rol \u00een dezvoltarea normal\u0103 a ovarelor.<\/p>\n<ol>\n<li><strong><u>EPUIZAREA ACCELERAT\u0102 A FOLICULILOR<\/u><\/strong><\/li>\n<\/ol>\n<p>Cauzele genetice, autoimune, de mediu sau toxice ale insuficien\u021bei ovariene primare (POI), denumit\u0103 anterior insuficien\u021b\u0103 ovarian\u0103 prematur\u0103 (POF), au adesea ca rezultat o epuizare accelerat\u0103 a foliculilor. Deple\u021bia folicular\u0103 complet\u0103 indic\u0103 faptul c\u0103 nu mai exist\u0103 foliculi primordiali \u00een ovar. Pentru majoritatea femeilor, acest proces este, de obicei, complet p\u00e2n\u0103 la aproximativ 51 de ani (v\u00e2rsta medie a menopauzei). Cu toate acestea, rata de epuizare a foliculilor poate fi accelerat\u0103 de o serie de tulbur\u0103ri genetice \u0219i toxice la nivel ovarian, ceea ce duce la menopauz\u0103 precoce.<\/p>\n<p>Cauze genetice<\/p>\n<p>Exist\u0103 din ce \u00een ce mai multe dovezi c\u0103 cauza genetic\u0103 a POI este eterogen\u0103. Secven\u021bierea \u00eentregului exom sau a \u00eentregului genom poate identifica cauza POI la aproximativ 30 p\u00e2n\u0103 la 35 la sut\u0103 dintre pacien\u021bi. Cauze genetice suplimentare continu\u0103 s\u0103 fie identificate, dar nu au fost dezvoltate inca terapii. Panourile de gene disponibile \u00een comer\u021b nu includ toate genele susceptibile de a fi importante \u0219i, p\u00e2n\u0103 \u00een prezent, nu au devenit disponibile terapii bazate pe testele genetice. Prin urmare, nu recomand\u0103m \u00eenc\u0103 testarea genetic\u0103 de rutin\u0103.<\/p>\n<p><strong>Tulbur\u0103ri ale cromozomului X<\/strong><\/p>\n<p>Sindromul Turner &#8211; Lipsa celui de-al doilea cromozom X (sindromul Turner) este cea mai frecvent\u0103 anomalie cromozomial\u0103 la om, ap\u0103r\u00e2nd \u00een p\u00e2n\u0103 la 1,5% din concep\u021bii, 10% din avorturile spontane \u0219i 1 din 2500 de na\u0219teri. Este, de asemenea, una dintre cele mai frecvente cauze de PDI.<\/p>\n<p>\u00cen mod caracteristic, ovarele din sindromul Turner sunt formate din cantit\u0103\u021bi mici de \u021besut conjunctiv \u0219i nu au foliculi sau au doar c\u00e2\u021biva foliculi atretici (&#8222;gonade striate&#8221;). Cazurile raportate ini\u021bial prezentau forme extreme ale acestui fenotip, cu dezvoltare pubertar\u0103 absent\u0103, amenoree primar\u0103 \u0219i multiple defecte morfologice; cu toate acestea, gradul de disfunc\u021bie ovarian\u0103 \u0219i amploarea defectelor sunt variabile. \u00cen timp ce majoritatea femeilor afectate nu au dezvoltare pubertar\u0103 \u0219i amenoree primar\u0103, unele se dezvolt\u0103 normal \u0219i apoi au amenoree secundar\u0103, iar altele nu au defecte morfologice \u0219i au o statur\u0103 normal\u0103.<\/p>\n<p>Studiile histologice timpurii ale ovarelor a opt fetu\u0219i XO stau la baza \u00een\u021belegerii insuficien\u021bei gonadelor \u00een sindromul Turner. Aceste ovare con\u021bineau un num\u0103r aparent normal de celule germinale primordiale p\u00e2n\u0103 la cel pu\u021bin 12 s\u0103pt\u0103m\u00e2ni de gesta\u021bie, dar la v\u00e2rstele gesta\u021bionale ulterioare, num\u0103rul de celule germinale era sc\u0103zut \u0219i \u021besutul conjunctiv era crescut, \u00een compara\u021bie cu fetu\u0219ii normali de v\u00e2rst\u0103 corespunz\u0103toare. Aceste rezultate indic\u0103 faptul c\u0103 insuficien\u021ba ovarian\u0103 este mai probabil cauzat\u0103 de atrezia accelerat\u0103 dec\u00e2t de formarea anormal\u0103 a celulelor germinale. Diagnosticul de sindrom Turner este stabilit prin analiza cariotipic\u0103.<\/p>\n<p><strong>Alte dele\u021bii\/transloca\u021bii ale cromozomului X <\/strong><\/p>\n<p>\u00cen plus fa\u021b\u0103 de monosomia X \u0219i dele\u021biile din bra\u021bul scurt al cromozomului X care cauzeaz\u0103 sindromul Turner, dele\u021biile, inversiunile \u0219i duplica\u021biile cromozomului X \u0219i transloca\u021biile echilibrate ale cromozomului X c\u0103tre un autozom sunt cele mai frecvente cauze ale POI. Micile dele\u021bii \u0219i puncte de ruptur\u0103 \u00een cromozomii X transloca\u021bi conduc la identificarea unei regiuni a cromozomului X critice pentru dezvoltarea \u0219i func\u021bia ovarian\u0103: Xq13 p\u00e2n\u0103 la Xq26, cu excep\u021bia Xq22. Din p\u0103cate, cartografierea loca\u021biei precise a acestor puncte de ruptur\u0103 nu a elucidat genele implicate \u00een func\u021bia ovarian\u0103, deoarece o gen\u0103 nu a fost \u00eentrerupt\u0103 sau gena \u00eentrerupt\u0103 nu a avut nicio leg\u0103tur\u0103 cu func\u021bia ovarian\u0103. Excep\u021bie face diafanul (DIAPH2), care a fost identificat la un punct de ruptur\u0103 \u00eentr-o transloca\u021bie de la cromozomul X la autozom la o femeie cu amenoree secundar\u0103. Muta\u021biile \u00een omologul diafanului din Drosophila melanogaster DIAPH2 perturb\u0103 oogeneza \u0219i spermatogeneza, sus\u021bin\u00e2nd un rol pentru DIAPH2 \u00een func\u021bia ovarian\u0103.<\/p>\n<p><strong>Purt\u0103toare de premuta\u021bii pentru sindromul X fragil<\/strong><\/p>\n<p>Exist\u0103 o rela\u021bie puternic\u0103 \u00eentre v\u00e2rsta la menopauz\u0103, inclusiv POI, \u0219i premuta\u021biile pentru sindromul X fragil (gena ribonucleoproteinei mesagerului X fragil 1 [FMR1]). Sindromul X fragil este o form\u0103 de dizabilitate intelectual\u0103 legat\u0103 de X care este una dintre cele mai frecvente cauze de \u00eent\u00e2rziere a dezvolt\u0103rii la nivel mondial.<\/p>\n<p>Genetica acestui sindrom este complex\u0103. Subiec\u021bii afecta\u021bi au mai mult de 200 de repet\u0103ri CGG \u00een regiunea netranslatat\u0103 5&#8242; a genei FMR1; ca urmare, o muta\u021bie complet\u0103 se refer\u0103 la o alel\u0103 cu mai mult de 200 de repet\u0103ri. Alelele cu mai pu\u021bin de 40 CGG sunt normale, lungimile de repeti\u021bie \u00eentre 40 \u0219i 55 sunt intermediare sau &#8222;zona gri&#8221;, iar lungimile de repeti\u021bie \u00eentre 55 \u0219i 200 sunt relativ instabile \u0219i se numesc &#8222;premuta\u021bii&#8221;. Premut\u0103rile se pot extinde p\u00e2n\u0103 la o muta\u021bie complet\u0103 atunci c\u00e2nd sunt transmise de c\u0103tre femele cu o rat\u0103 care depinde de num\u0103rul de repet\u0103ri. La masculi, premuta\u021bia poate r\u0103m\u00e2ne aceea\u0219i, se poate extinde la mai pu\u021bin de o muta\u021bie complet\u0103 sau chiar poate regresa atunci c\u00e2nd este transmis\u0103. De men\u021bionat c\u0103 termenul de premuta\u021bie este definit pe baza capacit\u0103\u021bii repet\u0103rii de a se extinde la o muta\u021bie complet\u0103 \u00eentr-o singur\u0103 genera\u021bie. Unele studii sugereaz\u0103 c\u0103 &#8222;zona gri&#8221; sau alelele de repeti\u021bie intermediare, care se pot extinde p\u00e2n\u0103 la o muta\u021bie complet\u0103 pe parcursul a dou\u0103 sau mai multe genera\u021bii, pot fi, de asemenea, asociate cu POI.<\/p>\n<p>Purt\u0103torii premut\u0103rii genei FMR1 care au lungimi de repeti\u021bie de la 55 la 200 au fost considera\u021bi ini\u021bial ca fiind neafecta\u021bi, deoarece nu au problemele grave de neurodezvoltare asociate cu muta\u021bia complet\u0103. Cu toate acestea, pe l\u00e2ng\u0103 POI, purt\u0103torii de premuta\u021bie, \u00een special b\u0103rba\u021bii, pot prezenta sindromul tremor-ataxie asociat cu X fragil (FXTAS) sau deficite cognitive \u0219i comportamentale u\u0219oare din spectrul celor observate \u00een sindromul X fragil.<\/p>\n<p>Procentul purt\u0103toarelor de premuta\u021bie care au menopauz\u0103 \u00eenainte de v\u00e2rsta de 40 de ani variaz\u0103 \u00eentre 12 \u0219i 28%. Num\u0103rul de repet\u0103ri CGG din intervalul de premuta\u021bie pare s\u0103 influen\u021beze momentul menopauzei. \u00cen plus fa\u021b\u0103 de efectul mare al unei premuta\u021bii asupra func\u021biei ovariene, variantele comune asociate cu v\u00e2rsta natural\u0103 la menopauz\u0103, precum \u0219i variantele modificatoare rare par s\u0103 joace un rol \u00een riscul de POI la aceste paciente.<\/p>\n<p>Mecanismul prin care o premuta\u021bie determin\u0103 insuficien\u021ba ovarian\u0103 nu este cunoscut. Subiec\u021bii cu premuta\u021bii par s\u0103 aib\u0103 o expresie crescut\u0103 a ARNm FMR1 \u0219i o protein\u0103 FMR1 diminuat\u0103, dar nu absent\u0103. \u00cen compara\u021bie, muta\u021biile complete la subiec\u021bii cu dizabilitate intelectual\u0103 sunt asociate cu metilarea genei FMR1 \u0219i lipsa transcrip\u021biei \u0219i a produc\u021biei de proteine.<\/p>\n<p>Nu exist\u0103 nicio asociere \u00eentre POI \u0219i muta\u021biile FMR1 complete. Prin urmare, deoarece purt\u0103torii de premuta\u021bii au o cantitate normal\u0103 de proteine, se postuleaz\u0103 c\u0103 nivelurile crescute de ARNm provoac\u0103 un efect toxic.<\/p>\n<p>De\u0219i menopauza precoce apare la mai pu\u021bin de o treime dintre pacientele cu premuta\u021bii, restul prezint\u0103 modific\u0103ri hormonale de \u00eemb\u0103tr\u00e2nire ovarian\u0103 timpurie, \u00een timp ce prezint\u0103 \u00eenc\u0103 cicluri menstruale regulate. Femeile purt\u0103toare de premuta\u021bie \u0219i care au copii sau rude afectate de sindromul X fragil au o menopauz\u0103 mai timpurie \u00een compara\u021bie cu femeile din lotul control, iar v\u00e2rsta menopauzei depinde de lungimea repeti\u021biei premuta\u021biei. Acest lucru a fost ilustrat, de asemenea, \u00eentr-un studiu efectuat pe 11 femei afectate cu v\u00e2rste cuprinse \u00eentre 24 \u0219i 41 de ani \u0219i pe 22 de femei de control de v\u00e2rst\u0103 corespunz\u0103toare, care au fost supuse zilnic unor probe de s\u00e2nge pentru determinarea nivelului de gonadotropin\u0103, steroizi sexuali \u0219i inhibin\u0103, cu urm\u0103toarele rezultate:<\/p>\n<ul>\n<li>Durata fazei foliculare a fost semnificativ mai scurt\u0103 la purt\u0103toare \u00een compara\u021bie cu cele din lotul control (12,9 fa\u021b\u0103 de 14,5 zile).<\/li>\n<li>Concentra\u021biile de estradiol seric nu au fost diferite \u00eentre grupuri, dar concentra\u021biile medii ale hormonului de stimulare a foliculului (FSH) \u00een faza folicular\u0103 au fost mai mari la purt\u0103toarele premuta\u021biei (21,9 fa\u021b\u0103 de 11,2 unit\u0103\u021bi interna\u021bionale\/L).<\/li>\n<li>Concentra\u021biile de inhibin\u0103 B \u00een faza folicular\u0103 \u0219i concentra\u021biile de inhibin\u0103 A \u0219i progesteron \u00een faza luteal\u0103 au fost mai mici la purt\u0103toarele premuta\u021biei comparativ cu cele ale martorilor, modific\u0103ri \u00een concordan\u021b\u0103 cu \u00eemb\u0103tr\u00e2nirea ovarelor.<\/li>\n<\/ul>\n<p>O problem\u0103 separat\u0103 este frecven\u021ba premut\u0103rilor X fragile la femeile cu POI sporadic\u0103 sau familial\u0103, care a fost abordat\u0103 \u00een mai multe studii. Prevalen\u021ba premut\u0103rilor FMR1 variaz\u0103 de la 2 la 5 la sut\u0103 la femeile cu POI sporadic\u0103 \u0219i de la 12 la 14 la sut\u0103 la femeile cu POI cu cel pu\u021bin un membru al familiei care a avut, de asemenea, menopauz\u0103 \u00eenainte de v\u00e2rsta de 40 de ani. Frecven\u021ba premut\u0103rilor X-fragil la femeile normale este estimat\u0103 la aproximativ 1 la 259.<\/p>\n<p>Astfel, Colegiul American al Obstetricienilor \u0219i Ginecologilor (ACOG) recomand\u0103 \u00een prezent ca femeile cu POI sau cu un nivel ridicat de FSH \u00eenainte de v\u00e2rsta de 40 de ani, f\u0103r\u0103 o cauz\u0103 cunoscut\u0103, s\u0103 fie supuse unui screening pentru depistarea premut\u0103rilor FMR1.<\/p>\n<p>De\u0219i femeile cu POI au o infertilitate relativ\u0103, multe dintre ele \u00eenc\u0103 \u00eencearc\u0103 \u00een mod activ s\u0103 conceap\u0103 atunci c\u00e2nd se pune diagnosticul de POI. Descoperirea faptului c\u0103 poate fi purt\u0103toare a unei alele de \u00eent\u00e2rziere a dezvolt\u0103rii (deoarece premuta\u021biile sunt instabile) poate ajuta aceste femei s\u0103 \u00ee\u0219i rezolve decizia de a r\u0103m\u00e2ne \u00eens\u0103rcinate cu propriile ovocite. \u00cen plus, identificarea statutului de purt\u0103tor este posibil s\u0103 determine depistarea surorilor \u0219i veri\u0219oarelor care sunt \u00eenc\u0103 fertile, iar descoperirea statutului de purt\u0103tor al virusului X fragil poate exclude o sor\u0103 ca poten\u021bial\u0103 donatoare de ovocite.<\/p>\n<p><strong>Defecte cromozomiale somatice<\/strong><\/p>\n<p><em>Galactozemia<\/em> &#8211; Galactozemia este o boala cu transmitere autosomal recesiva, caracterizata prin perturbarea metabolismului galactozei cu aparitia unor complicatii ce pot pune viata nou-nascutului in pericol. Deficienta GALT duce la acumulare de galactozo-1-fosfat si galactoza in tesuturi, in special ficat, creier sau rinichi. Se crede ca\u00a0<a href=\"http:\/\/www.medicultau.com\/boli-si-tratamente\/folosirea-fructelor-florilor-in-terapia-diverselor-boli\/ciroza-hepatica.php\" target=\"_blank\" rel=\"noopener\">afectarea<\/a>\u00a0hepatica (ciroza) si retardul mental induse de galactozemia depind de \u00a0cantitatea de galactozo-1-fosfat depusa in aceste tesuturi. Galactoza este convertita la galactitol in celule si produce efecte osmotice, cum ar fi edematierea fibrelor cristalinului ce poate conduce la\u00a0<em>cataracta<\/em>\u00a0si a neuronilor, care poate determina\u00a0<em>pseudotumor cerebri<\/em>. Cataracta se dezvolta secundar acumularii de galactitol la nivelul cristalinului. POI este frecvent\u0103 la femeile cu galactozemie. Deoarece hipogonadismul nu poate fi eliminat prin control metabolic precoce, se crede c\u0103 este cauzat de efectele toxice ale metaboli\u021bilor galactozei, mai degrab\u0103 dec\u00e2t de anomalii \u00een compozi\u021bia carbohidra\u021bilor din gonadotropine care reduc bioactivitatea acestora. Chiar \u0219i defectele subtile \u00een metabolismul galactozei pot avea un impact asupra func\u021biei ovariene. \u00centr-un studiu efectuat pe 104 femei normale aflate la postmenopauz\u0103, 15 dintre acestea au prezentat o activitate sc\u0103zut\u0103 a galactozei-1-fosfat uridil transferazei \u0219i o alel\u0103 anormal\u0103 a transferazei prin electroforez\u0103 \u00een gel; aceste femei au avut o v\u00e2rst\u0103 medie mai mic\u0103 la menopauz\u0103 (45 fa\u021b\u0103 de 49 de ani).<\/p>\n<p>\u00cen schimb, \u00eentr-un al doilea raport privind 58 de femei aflate \u00een pre \u0219i postmenopauz\u0103 care erau heterozigote pentru muta\u021bia clasic\u0103 a galactosemiei, nu au existat diferen\u021be \u00een ceea ce prive\u0219te markerii serici ai \u00eemb\u0103tr\u00e2nirii ovariene (FSH, inhibina B, hormonul anti-m\u00fcllerian) sau num\u0103rul de foliculi antrali la ecografie la cele 42 de purt\u0103toare aflate \u00een premenopauz\u0103 \u00een compara\u021bie cu o cohort\u0103 de femei fertile dovedite. \u00cen plus, v\u00e2rsta medie la menopauz\u0103 la purt\u0103toarele aflate \u00een postmenopauz\u0103 a fost de 49,7 ani, care nu difer\u0103 de cea observat\u0103 \u00een popula\u021bia general\u0103.<\/p>\n<p><em>Genele asociate cu disgenesia gonadic\u0103 46,XX &#8211;<\/em> Au fost descoperite o serie de gene noi cu ajutorul secven\u021bierii \u00eentregului exom la familiile consangvinizate. Aceste muta\u021bii, care par a fi rare, cauzeaz\u0103 amenoree primar\u0103 asociat\u0103 cu POI (disgenesie gonadic\u0103 XX). Majoritatea muta\u021biilor identificate \u00een aceste familii consangvine \u00een absen\u021ba altor tr\u0103s\u0103turi sindromice au fost g\u0103site \u00een gene importante pentru meioz\u0103, recombinare omoloag\u0103 \u0219i deteriorarea \u0219i repararea ADN-ului. \u00cen mod interesant, unele dintre genele implicate se suprapun cu regiuni ale genomului cu variante comune care sunt asociate cu v\u00e2rsta menopauzei \u00een popula\u021bia general\u0103. Acestea includ:<\/p>\n<ul>\n<li>STAG3 &#8211; O dele\u021bie homozigot\u0103, recesiv\u0103 a perechilor de baze \u00een STAG3, o subunitate specific\u0103 meiozei a inelului de coeziune, care este responsabil\u0103 pentru sinapsarea corect\u0103 a cromatidelor surori. Ovocitele la \u0219oarecii cu dele\u021bii STAG3 sunt oprite \u00een stadiul de profaz\u0103 I, neput\u00e2nd s\u0103 finalizeze meioza, ceea ce duce la pierderea ovocitelor.<\/li>\n<li>SYCE1, MCM8, MCM9, SPIDR, MARF1 \u0219i PSMC3IP. Aceste gene joac\u0103, de asemenea, un rol \u00een recombinare \u00een timpul meiozei I prin rupturi \u0219i repararea ADN-ului.<\/li>\n<li>BRCA2 &#8211; Muta\u021bii de trunchiere a proteinei compuse, heterozigote \u00een BRCA2, care au ca rezultat niveluri reduse de proteine, au fost identificate la surori cu disgenesie gonadic\u0103 XX, microcefalie \u0219i leucemie cu debut precoce la una dintre surori. Muta\u021bia are ca rezultat o deteriorare a repar\u0103rii daunelor ADN dublu catenar.<\/li>\n<li>ESR2 &#8211; O muta\u021bie de pierdere a func\u021biei heterozigot\u0103 missense \u00een gena receptorului beta al estrogenului (ESR2) a fost identificat\u0103 la o femeie de 16 ani cu disgenesie gonadic\u0103 XX \u0219i osteoporoz\u0103. Muta\u021bia (\u00eentr-un domeniu de legare a co-factoriului) a \u00eentrerupt semnalizarea estradiolului \u0219i a demonstrat un efect dominant negativ, suger\u00e2nd un rol critic a ESR2 in dezvoltarea ovariana.<\/li>\n<\/ul>\n<p><em>Alte gene<\/em><\/p>\n<ul>\n<li>FIGLA &#8211; FIGLA este un factor de transcrip\u021bie specific ovocitelor care s-a demonstrat c\u0103 poart\u0103 variante heterozigote care afecteaz\u0103 func\u021bia genei \u00eentr-un studiu de gene candidate la 100 de femei de etnie chinez\u0103 Han.<\/li>\n<li>NOBOX &#8211; S-a demonstrat c\u0103 muta\u021biile heterozigote \u00een NOBOX, homeodomainul care se leag\u0103 de elementul de legare a ADN-ului NOBOX (NBE), cauzeaz\u0103 o \u00eentrerupere dominant\u0103, negativ\u0103 a leg\u0103rii ADN-ului \u0219i sunt implicate \u00een POI.<\/li>\n<li>Gene suplimentare au fost identificate \u00een cazuri sporadice sau familiale de POI. O muta\u021bie heterozigot\u0103 rar\u0103 f\u0103r\u0103 sens \u00een factorul de import nuclear 1 al factorului de ini\u021biere a traducerii eucariote 4E (eIF4ENIF1) a fost identificat\u0103 \u00eentr-o familie cu nou\u0103 femei din trei genera\u021bii consecutive care au dezvoltat menopauza la aproximativ 30 de ani, suger\u00e2nd o mo\u0219tenire dominant\u0103. \u00centreruperea genei afecteaz\u0103 traducerea proteinelor \u0219i meioza .<\/li>\n<li>BMP15 &#8211; O muta\u021bie \u00een proteina pentru morfogeneza osoas\u0103-15 (BMP15), un regulator al ovula\u021biei \u0219i foliculogenezei \u00een modelele animale \u0219i un membru al familiei TGF care include activina \u0219i inhibina, a fost identificat\u0103 ini\u021bial la dou\u0103 femei cu POI. \u00cen testele func\u021bionale, BMP15 mutant a fost procesat \u00een mod anormal, asociat cu o cre\u0219tere redus\u0103 a celulelor granuloase \u0219i a antagonizat efectul stimulator al BMP15 de tip s\u0103lbatic asupra prolifer\u0103rii celulelor granuloase. \u00centr-un studiu de urm\u0103rire a 166 de pacien\u021bi cu POI care au fost supu\u0219i unui screening genetic, s-a constatat c\u0103 \u0219apte (4,2 la sut\u0103) aveau una dintre cele trei muta\u021bii heterozigote \u00een gena BMP15. Aceste muta\u021bii nu au fost g\u0103site \u00een grupurile de control formate din 95 de femei care au avut menopauz\u0103 natural\u0103 dup\u0103 v\u00e2rsta de 50 de ani \u0219i 116 subiec\u021bi din popula\u021bia general\u0103.<\/li>\n<\/ul>\n<p><strong>Alte defecte sindromice rare<\/strong> &#8211; Mai multe tulbur\u0103ri neurologice, oncologice \u0219i alte tulbur\u0103ri sindromice se prezint\u0103 cu POI, ceea ce indic\u0103 efectele pleiotropice ale genelor implicate. Acestea includ:<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li>Muta\u021bii \u00een gena FOXL2, care sunt asociate cu sindromul blefarofimoz\u0103\/ptosis\/epicanthus inversus (BPES). BPES de tip I, dar nu \u0219i de tip II, este asociat cu POI. \u00cen plus, au fost descrise muta\u021bii \u00een FOXL2 la pacien\u021bii cu POI izolat\u0103.<\/li>\n<li>Ataxia telangiectazia se prezint\u0103 clinic cu mers instabil, degenerare motorie progresiv\u0103, vase de s\u00e2nge dilatate (telangiectazii) \u0219i insuficien\u021b\u0103 a celulelor germinale. Sunt responsabile muta\u021biile \u00een ataxia telangiectaziei mutante (ATM), o protein\u0103 kinaz\u0103 care joac\u0103 un rol \u00een r\u0103spunsul celular la leziuni genomice. Modelele de \u0219oareci sugereaz\u0103 c\u0103 ATM monitorizeaz\u0103 progresia normal\u0103 a meiozei.<\/li>\n<\/ul>\n<p><strong>Insuficien\u021ba ovarian\u0103 autoimun\u0103 <\/strong><\/p>\n<p>Autoimunitatea a fost postulat\u0103 pentru prima dat\u0103 ca fiind o cauz\u0103 a POI atunci c\u00e2nd s-a observat c\u0103 unele femei cu insuficien\u021b\u0103 suprarenal\u0103 prezentau \u0219i insuficien\u021b\u0103 ovarian\u0103. Printre aceste femei se num\u0103r\u0103 multe dintre cele cu sindroame de tip I \u0219i II de insuficien\u021b\u0103 autoimun\u0103 poliglandular\u0103, care sunt asociate cu autoanticorpi la mai multe organe endocrine \u0219i la alte organe. De asemenea, a fost raportat\u0103 o posibil\u0103 asociere \u00eentre miastenia gravis \u0219i POI.<\/p>\n<p>Exist\u0103 dovezi histologice puternice c\u0103 POI, atunci c\u00e2nd apare \u00een asociere cu autoimunitatea suprarenal\u0103, este o entitate specific\u0103 mediat\u0103 de o infiltra\u021bie limfocitar\u0103 intens\u0103 a celulelor tecale. \u00cen aceast\u0103 afec\u021biune, foliculii primordiali sunt cru\u021ba\u021bi, de\u0219i exist\u0103 probabil o r\u0103sp\u00e2ndire a infiltratului inflamator cu timpul. Teoretic, func\u021bia ovarian\u0103 ar putea fi restabilit\u0103 dac\u0103 ar putea fi elaborat \u0219i utilizat un regim imunosupresor sigur \u0219i eficient la \u00eenceputul evolu\u021biei.<\/p>\n<p>\u00centr-o analiza, 4% dintre femeile cu 46,XX si POI prezentau ooforit\u0103 autoimun\u0103 limfocitar\u0103 \u0219i anticorpi antiadrenali pozitivi. Nu se cunoa\u0219te frecven\u021ba ooforitei autoimune \u00een r\u00e2ndul femeilor cu insuficien\u021b\u0103 ovarian\u0103 f\u0103r\u0103 insuficien\u021b\u0103 suprarenal\u0103 coexistent\u0103.<\/p>\n<p><strong>Toxice ovariene <\/strong><\/p>\n<p>Toxicele ovariene asociate cu POI includ chimioterapia \u0219i radioterapia. Infec\u021biile virale au fost suspectate, dar nu au fost stabilite relatii cauzale clare.<\/p>\n<p><em>Chimioterapie\/radioterapie<\/em> &#8211; Medicamentele chimioterapeutice \u0219i radioterapia sunt cele mai frecvente cauze de insuficien\u021b\u0103 ovarian\u0103 indus\u0103 de toxine.<\/p>\n<p><em>Virusuri<\/em> &#8211; Viru\u0219i precum oreionul au fost asocia\u021bi cu orhita \u0219i insuficien\u021ba testicular\u0103 la b\u0103rba\u021bi \u0219i, prin urmare, s-a presupus c\u0103 pot cauza ooforit\u0103 \u0219i insuficien\u021b\u0103 ovarian\u0103 la femei. Cu toate acestea, ooforita acut\u0103 este mult mai dificil de diagnosticat la femei dec\u00e2t este orhita la b\u0103rba\u021bi, iar majoritatea dovezilor c\u0103 infec\u021biile virale pot provoca hipogonadism primar la femei sunt circumstan\u021biale. De\u0219i ooforita viral\u0103 a fost indus\u0103 experimental la vaci, pu\u021bine cazuri de infec\u021bie viral\u0103 a ovarelor au fost documentate histologic la femei. Un raport a descris o femeie cu o infec\u021bie generalizat\u0103 cu citomegalovirus (CMV) care a avut dovezi histologice de ooforit\u0103 CMV la autopsie; cu toate acestea, ea nu a avut nicio dovad\u0103 clinic\u0103 de hipogonadism. \u00cen timp ce unele femei cu hipogonadism primar \u00ee\u0219i pot aminti o boal\u0103 viral\u0103 anterioar\u0103, nu a fost stabilit\u0103 o rela\u021bie cauz\u0103-efect.<\/p>\n<p><em>Altele<\/em> &#8211; Alte toxine pot avea efecte mai subtile asupra func\u021biei ovariene. De exemplu, fum\u0103toarele de \u021big\u0103ri ajung la menopauz\u0103 cu aproximativ doi ani mai devreme dec\u00e2t nefum\u0103toarele. Factorii endogeni care se coreleaz\u0103 cu v\u00e2rsta la menopauz\u0103 includ greutatea \u0219i statutul socioeconomic, care o cresc, \u0219i paritatea, care o scade.<\/p>\n<ol start=\"2\">\n<li><strong><u>HIPOGONADISM PRIMAR F\u0102R\u0102 DEPLE\u021aIE FOLICULAR\u0102<\/u><\/strong><\/li>\n<\/ol>\n<p>Unele tulbur\u0103ri care nu sunt asociate cu deple\u021bia folicular\u0103 se pot prezenta clinic ca hipogonadism primar. Aceste tulbur\u0103ri sunt tulbur\u0103ri genetice ale produc\u021biei de precursori de estradiol sau ale func\u021biei aromatazei, care determin\u0103 sc\u0103derea estradiolului \u0219i absen\u021ba feedback-ului negativ normal al hormonului de stimulare a foliculilor (FSH).<\/p>\n<p>Exist\u0103 dou\u0103 mecanisme majore ale hipogonadismului primar f\u0103r\u0103 epuizarea foliculilor: mediatorii endogeni de activare a receptorilor de gonadotropin\u0103 \u0219i defectele enzimelor steroidogene care \u00eempiedic\u0103 produc\u021bia de estradiol. Secre\u021bia de gonadotropine biologic inactive, o cauz\u0103 a hipogonadismului secundar, se prezint\u0103 \u00eentr-un mod similar cu insuficien\u021ba ovarian\u0103 primar\u0103 (POI), \u00een sensul c\u0103 concentra\u021biile serice de gonadotropine imunoreactive sunt ridicate.<\/p>\n<p><em>Modulatori intraovariani<\/em><\/p>\n<p>Au fost identificate multe substan\u021be care pot servi ca regulatori paracrini ai capacit\u0103\u021bii de r\u0103spuns ovarian. Produc\u021bia ovarian\u0103 anormal\u0103 a oric\u0103ruia dintre ace\u0219ti modulatori ar putea cauza hipogonadismul primar, fie direct, fie prin diminuarea r\u0103spunsurilor celulare la gonadotropine. Cu toate acestea, numai polimorfismele din subunitatea alfa a inhibinei au fost implicate \u00een insuficien\u021ba ovarian\u0103 .<\/p>\n<p><em>Defecte ale enzimelor steroidogene<\/em><\/p>\n<p>Unele dintre cauzele mai pu\u021bin frecvente ale hiperplaziei congenitale suprarenale se datoreaz\u0103 unor defecte genetice ale enzimelor implicate \u00een biosinteza androstenedionei \u0219i estradiolului, pe l\u00e2ng\u0103 biosinteza cortizolului. Aceste defecte determin\u0103 concentra\u021bii sc\u0103zute de estrogen \u0219i, prin urmare, concentra\u021bii serice ridicate de FSH. De\u0219i aceste tulbur\u0103ri nu sunt asociate cu deple\u021bia folicular\u0103, pacien\u021bii prezint\u0103 hipogonadism hipergonadotropic.<\/p>\n<p>Defectele enzimatice raportate includ muta\u021bii \u00een:<\/p>\n<ul>\n<li><em>Enzima de reglare acut\u0103 steroidogenic\u0103<\/em> (StAR), enzima care deplaseaz\u0103 colesterolul de la membrana mitocondrial\u0103 extern\u0103 la cea intern\u0103. Pacien\u021bii cu hiperplazie lipoid\u0103 congenital\u0103 cauzat\u0103 de muta\u021bii StAR prezint\u0103 de obicei insuficien\u021b\u0103 suprarenal\u0103 sever\u0103 foarte cur\u00e2nd dup\u0103 na\u0219tere, de\u0219i ocazional se prezint\u0103 mai t\u00e2rziu \u00een copil\u0103rie. La pacien\u021bii trata\u021bi cu substitu\u021bie steroidic\u0103 precoce, exist\u0103 absen\u021ba dezvolt\u0103rii pubertare.<\/li>\n<li><em>Pacien\u021bii cu deficit de CYP17<\/em> se prezint\u0103, de obicei, aproximativ la momentul a\u0219teptat al pubert\u0103\u021bii, din cauza hipertensiunii, hipokaliemiei \u0219i hipogonadismului. Pacien\u021bii de sex feminin (46,XX) au amenoree primar\u0103 \u0219i absen\u021ba caracteristicilor sexuale secundare.<\/li>\n<\/ul>\n<p><strong>Muta\u021bii ale receptorilor FSH<\/strong><\/p>\n<p>Defectele specifice ale receptorilor fac ca ovarele unor femei cu POI s\u0103 nu r\u0103spund\u0103 la FSH \u0219i la hormonul luteinizant (LH). Muta\u021biile genei pentru receptorul FSH (sau LH) care au ca rezultat producerea de receptori care fie nu se leag\u0103 de FSH, fie nu pot transduce semnalul ini\u021biat \u00een mod normal prin legarea hormonului de receptor ar trebui s\u0103 cauzeze hipogonadism primar. O muta\u021bie a genei receptorului FSH care are ca rezultat producerea de receptori care se leag\u0103 slab de FSH a fost identificat\u0103 la unele femei tinere cu POI. Muta\u021bia a dus la o singur\u0103 substitu\u021bie de aminoacizi \u00een domeniul extracelular al receptorului FSH care \u00eempiedic\u0103 legarea FSH. Astfel, FSH nu stimuleaz\u0103 aromatizarea precursorilor la estradiol, iar femeile sunt deficitare \u00een estrogeni. R\u0103m\u00e2ne de stabilit dac\u0103 aceast\u0103 muta\u021bie afecteaz\u0103 num\u0103rul \u0219i viabilitatea ovocitelor. Efectul s\u0103u asupra fertilit\u0103\u021bii masculine este variabil.<\/p>\n<p>S-a raportat, de asemenea, o <strong>muta\u021bie \u00een gena receptorului LH<\/strong>. Acest defect a fost identificat la b\u0103rba\u021bii care aveau hipogonadism, iar o femeie afectat\u0103 din familie avea amenoree secundar\u0103 cu concentra\u021bii serice ridicate de LH, dar normale de FSH.<\/p>\n<p><strong>Muta\u021bii ale genei subunit\u0103\u021bii Gs alfa<\/strong><\/p>\n<p>\u00cen plus fa\u021b\u0103 de defectele receptorilor de gonadotropine, au fost descrise defecte \u00een proteina de reglare a nucleotidelor de guanin\u0103 a adenilatciclazei (proteina G) care este legat\u0103 de receptori \u0219i prin intermediul c\u0103reia receptorii activa\u021bi stimuleaz\u0103 activitatea adenilatciclazei. A\u0219a cum era de a\u0219teptat din multitudinea de receptori activa\u021bi de acelea\u0219i proteine G, inclusiv receptorii hormonului paratiroidian, FSH, LH \u0219i ai tirotropinei, subiec\u021bii afecta\u021bi pot avea pseudohipoparatiroidism, func\u021bie gonadic\u0103 anormal\u0103 \u0219i hipotiroidism, printre alte probleme.<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Bibliografie:<\/strong><\/p>\n<ol>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/1\" target=\"_blank\" rel=\"noopener\">Nelson LM, Anasti JN, Kimzey LM, et al. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. J Clin Endocrinol Metab 1994; 79:1470.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/2\" target=\"_blank\" rel=\"noopener\">Taylor AE, Adams JM, Mulder JE, et al. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab 1996; 81:3615.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/3\" target=\"_blank\" rel=\"noopener\">Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009; 360:606.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/4\" target=\"_blank\" rel=\"noopener\">Rossetti R, Ferrari I, Bonomi M, Persani L. Genetics of primary ovarian insufficiency. Clin Genet 2017; 91:183.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/5\" target=\"_blank\" rel=\"noopener\">Eskenazi S, Bachelot A, Hugon-Rodin J, et al. Next Generation Sequencing Should Be Proposed to Every Woman With &#8222;Idiopathic&#8221; Primary Ovarian Insufficiency. J Endocr Soc 2021; 5:bvab032.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/6\" target=\"_blank\" rel=\"noopener\">Gorsi B, Hernandez E, Moore MB, et al. Causal and Candidate Gene Variants in a Large Cohort of Women With Primary Ovarian Insufficiency. J Clin Endocrinol Metab 2022; 107:685.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/7\" target=\"_blank\" rel=\"noopener\">Heddar A, Ogur C, Da Costa S, et al. Genetic landscape of a large cohort of Primary Ovarian Insufficiency: New genes and pathways and implications for personalized medicine. EBioMedicine 2022; 84:104246.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/8\" target=\"_blank\" rel=\"noopener\">Jacobs PA. The incidence and etiology of sex chromosome abnormalities in man. Birth Defects Orig Artic Ser 1979; 15:3.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/9\" target=\"_blank\" rel=\"noopener\">Hook EB, Warburton D. The distribution of chromosomal genotypes associated with Turner&#8217;s syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet 1983; 64:24.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/10\" target=\"_blank\" rel=\"noopener\">Albright F, Smith PH, Fraser R. A syndrome characterized by primary ovarian insufficiency and decreased stature: Report of 11 cases with a digression on hormonal control of axillary and pubic hair. Am J Med Sci 1942; 204:625.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/11\" target=\"_blank\" rel=\"noopener\">Singh RP, Carr DH. The anatomy and histology of XO human embryos and fetuses. Anat Rec 1966; 155:369.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/12\" target=\"_blank\" rel=\"noopener\">Schlessinger D, Herrera L, Crisponi L, et al. Genes and translocations involved in POF. Am J Med Genet 2002; 111:328.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/13\" target=\"_blank\" rel=\"noopener\">Bione S, Sala C, Manzini C, et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 1998; 62:533.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/14\" target=\"_blank\" rel=\"noopener\">Fryns JP. The female and the fragile X. A study of 144 obligate female carriers. Am J Med Genet 1986; 23:157.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/15\" target=\"_blank\" rel=\"noopener\">Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study&#8211;preliminary data. Am J Med Genet 1999; 83:322.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/16\" target=\"_blank\" rel=\"noopener\">de Vries BB, Halley DJ, Oostra BA, Niermeijer MF. The fragile X syndrome. J Med Genet 1998; 35:579.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/17\" target=\"_blank\" rel=\"noopener\">Bodega B, Bione S, Dalpr\u00e0 L, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 2006; 21:952.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/18\" target=\"_blank\" rel=\"noopener\">Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005; 117:376.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/19\" target=\"_blank\" rel=\"noopener\">Hagerman RJ, Leavitt BR, Farzin F, et al. Fragile-X-associated tremor\/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 2004; 74:1051.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/20\" target=\"_blank\" rel=\"noopener\">Greco CM, Hagerman RJ, Tassone F, et al. Neuronal intranuclear inclusions in a new cerebellar tremor\/ataxia syndrome among fragile X carriers. Brain 2002; 125:1760.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/21\" target=\"_blank\" rel=\"noopener\">Jacquemont S, Hagerman RJ, Leehey M, et al. Fragile X premutation tremor\/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 2003; 72:869.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/22\" target=\"_blank\" rel=\"noopener\">Sullivan AK, Marcus M, Epstein MP, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 2005; 20:402.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/23\" target=\"_blank\" rel=\"noopener\">Trevino CE, Rounds JC, Charen K, et al. Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation. Fertil Steril 2021; 116:843.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/24\" target=\"_blank\" rel=\"noopener\">Kenneson A, Zhang F, Hagedorn CH, Warren ST. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 2001; 10:1449.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/25\" target=\"_blank\" rel=\"noopener\">Tassone F, Hagerman RJ, Taylor AK, et al. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 2000; 91:144.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/26\" target=\"_blank\" rel=\"noopener\">Tassone F, Hagerman RJ, Taylor AK, et al. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 2000; 66:6.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/27\" target=\"_blank\" rel=\"noopener\">Mailick MR, Hong J, Greenberg J, et al. Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions. Am J Med Genet B Neuropsychiatr Genet 2014; 165B:705.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/28\" target=\"_blank\" rel=\"noopener\">Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 2004; 89:4569.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/29\" target=\"_blank\" rel=\"noopener\">Gersak K, Meden-Vrtovec H, Peterlin B. Fragile X premutation in women with sporadic premature ovarian failure in Slovenia. Hum Reprod 2003; 18:1637.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/30\" target=\"_blank\" rel=\"noopener\">Marozzi A, Vegetti W, Manfredini E, et al. Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 2000; 15:197.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/31\" target=\"_blank\" rel=\"noopener\">Uzielli ML, Guarducci S, Lapi E, et al. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet 1999; 84:300.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/32\" target=\"_blank\" rel=\"noopener\">Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 2000; 97:189.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/33\" target=\"_blank\" rel=\"noopener\">Rousseau F, Rouillard P, Morel ML, et al. Prevalence of carriers of premutation-size alleles of the FMRI gene&#8211;and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 1995; 57:1006.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/34\" target=\"_blank\" rel=\"noopener\">American College of Obstetricians and Gynecologists Committee on Genetics. ACOG committee opinion. No. 338: Screening for fragile X syndrome. Obstet Gynecol 2006; 107:1483.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/35\" target=\"_blank\" rel=\"noopener\">Chen YT, Mattison DR, Feigenbaum L, et al. Reduction in oocyte number following prenatal exposure to a diet high in galactose. Science 1981; 214:1145.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/36\" target=\"_blank\" rel=\"noopener\">Kaufman FR, Kogut MD, Donnell GN, et al. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981; 304:994.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/37\" target=\"_blank\" rel=\"noopener\">Cramer DW, Harlow BL, Barbieri RL, Ng WG. Galactose-1-phosphate uridyl transferase activity associated with age at menopause and reproductive history. Fertil Steril 1989; 51:609.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/38\" target=\"_blank\" rel=\"noopener\">Knauff EA, Richardus R, Eijkemans MJ, et al. Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age. Reprod Sci 2007; 14:780.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/39\" target=\"_blank\" rel=\"noopener\">Caburet S, Arboleda VA, Llano E, et al. Mutant cohesin in premature ovarian failure. N Engl J Med 2014; 370:943.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/40\" target=\"_blank\" rel=\"noopener\">AlAsiri S, Basit S, Wood-Trageser MA, et al. Exome sequencing reveals MCM8 mutation underlies ovarian failure and chromosomal instability. J Clin Invest 2015; 125:258.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/41\" target=\"_blank\" rel=\"noopener\">de Vries L, Behar DM, Smirin-Yosef P, et al. Exome sequencing reveals SYCE1 mutation associated with autosomal recessive primary ovarian insufficiency. J Clin Endocrinol Metab 2014; 99:E2129.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/42\" target=\"_blank\" rel=\"noopener\">Wood-Trageser MA, Gurbuz F, Yatsenko SA, et al. MCM9 mutations are associated with ovarian failure, short stature, and chromosomal instability. Am J Hum Genet 2014; 95:754.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/43\" target=\"_blank\" rel=\"noopener\">Smirin-Yosef P, Zuckerman-Levin N, Tzur S, et al. A Biallelic Mutation in the Homologous Recombination Repair Gene SPIDR Is Associated With Human Gonadal Dysgenesis. J Clin Endocrinol Metab 2017; 102:681.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/44\" target=\"_blank\" rel=\"noopener\">Day FR, Ruth KS, Thompson DJ, et al. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet 2015; 47:1294.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/45\" target=\"_blank\" rel=\"noopener\">Weinberg-Shukron A, Rachmiel M, Renbaum P, et al. Essential Role of BRCA2 in Ovarian Development and Function. N Engl J Med 2018; 379:1042.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/46\" target=\"_blank\" rel=\"noopener\">Lang-Muritano M, Sproll P, Wyss S, et al. Early-Onset Complete Ovarian Failure and Lack of Puberty in a Woman With Mutated Estrogen Receptor \u03b2 (ESR2). J Clin Endocrinol Metab 2018; 103:3748.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/47\" target=\"_blank\" rel=\"noopener\">Zhao H, Chen ZJ, Qin Y, et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet 2008; 82:1342.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/48\" target=\"_blank\" rel=\"noopener\">Qin Y, Choi Y, Zhao H, et al. NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet 2007; 81:576.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/49\" target=\"_blank\" rel=\"noopener\">Kasippillai T, MacArthur DG, Kirby A, et al. Mutations in eIF4ENIF1 are associated with primary ovarian insufficiency. J Clin Endocrinol Metab 2013; 98:E1534.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/50\" target=\"_blank\" rel=\"noopener\">Pfender S, Kuznetsov V, Pasternak M, et al. Live imaging RNAi screen reveals genes essential for meiosis in mammalian oocytes. Nature 2015; 524:239.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/51\" target=\"_blank\" rel=\"noopener\">Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 2004; 75:106.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/52\" target=\"_blank\" rel=\"noopener\">Di Pasquale E, Rossetti R, Marozzi A, et al. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab 2006; 91:1976.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/53\" target=\"_blank\" rel=\"noopener\">Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis\/ptosis\/epicanthus inversus syndrome. Nat Genet 2001; 27:159.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/54\" target=\"_blank\" rel=\"noopener\">Raile K, Stobbe H, Tr\u00f6bs RB, et al. A new heterozygous mutation of the FOXL2 gene is associated with a large ovarian cyst and ovarian dysfunction in an adolescent girl with blepharophimosis\/ptosis\/epicanthus inversus syndrome. Eur J Endocrinol 2005; 153:353.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/55\" target=\"_blank\" rel=\"noopener\">Settas N, Anapliotou M, Kanavakis E, et al. A novel FOXL2 gene mutation and BMP15 variants in a woman with primary ovarian insufficiency and blepharophimosis-ptosis-epicanthus inversus syndrome. Menopause 2015; 22:1264.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/56\" target=\"_blank\" rel=\"noopener\">Beysen D, De Paepe A, De Baere E. FOXL2 mutations and genomic rearrangements in BPES. Hum Mutat 2009; 30:158.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/57\" target=\"_blank\" rel=\"noopener\">Barlow C, Liyanage M, Moens PB, et al. Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I. Development 1998; 125:4007.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/58\" target=\"_blank\" rel=\"noopener\">Ellis NA, German J. Molecular genetics of Bloom&#8217;s syndrome. Hum Mol Genet 1996; 5 Spec No:1457.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/59\" target=\"_blank\" rel=\"noopener\">Fogli A, Rodriguez D, Eymard-Pierre E, et al. Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 2003; 72:1544.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/60\" target=\"_blank\" rel=\"noopener\">Pagnamenta AT, Taanman JW, Wilson CJ, et al. Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum Reprod 2006; 21:2467.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/61\" target=\"_blank\" rel=\"noopener\">Jenkinson EM, Clayton-Smith J, Mehta S, et al. Perrault syndrome: further evidence for genetic heterogeneity. J Neurol 2012; 259:974.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/62\" target=\"_blank\" rel=\"noopener\">Li Y, Xiao B, Xiao L, et al. Myasthenia gravis accompanied by premature ovarian failure and aggravation by estrogen. Intern Med 2010; 49:611.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/63\" target=\"_blank\" rel=\"noopener\">Ryan MM, Jones HR Jr. Myasthenia gravis and premature ovarian failure. Muscle Nerve 2004; 30:231.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/64\" target=\"_blank\" rel=\"noopener\">Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18:107.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/65\" target=\"_blank\" rel=\"noopener\">Morrison JC, Givens JR, Wiser WL, Fish SA. Mumps oophoritis: a cause of premature menopause. Fertil Steril 1975; 26:655.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/66\" target=\"_blank\" rel=\"noopener\">Smith PC, Nusbaum KE, Kwapien RP, et al. Necrotic oophoritis in heifers vaccinated intravenously with infectious bovine rhinotracheitis virus vaccine during estrus. Am J Vet Res 1990; 51:969.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/67\" target=\"_blank\" rel=\"noopener\">Williams DJ, Connor P, Ironside JW. Pre-menopausal cytomegalovirus oophoritis. Histopathology 1990; 16:405.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/68\" target=\"_blank\" rel=\"noopener\">Subietas A, Deppisch LM, Astarloa J. Cytomegalovirus oophoritis: ovarian cortical necrosis. Hum Pathol 1977; 8:285.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/69\" target=\"_blank\" rel=\"noopener\">Willett W, Stampfer MJ, Bain C, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol 1983; 117:651.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/70\" target=\"_blank\" rel=\"noopener\">McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med 1985; 103:350.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/71\" target=\"_blank\" rel=\"noopener\">Stanford JL, Hartge P, Brinton LA, et al. Factors influencing the age at natural menopause. J Chronic Dis 1987; 40:995.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/72\" target=\"_blank\" rel=\"noopener\">Shelling AN, Burton KA, Chand AL, et al. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 2000; 15:2644.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/73\" target=\"_blank\" rel=\"noopener\">Lin D, Sugawara T, Strauss JF 3rd, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995; 267:1828.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/74\" target=\"_blank\" rel=\"noopener\">Mallin SR. Congenital adrenal hyperplasia secondary to 17-hydroxylase deficiency. Two sisters with amenorrhea, hypokalemia, hypertension, and cystic ovaries. Ann Intern Med 1969; 70:69.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/75\" target=\"_blank\" rel=\"noopener\">Ito Y, Fisher CR, Conte FA, et al. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci U S A 1993; 90:11673.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/76\" target=\"_blank\" rel=\"noopener\">Louren\u00e7o D, Brauner R, Lin L, et al. Mutations in NR5A1 associated with ovarian insufficiency. N Engl J Med 2009; 360:1200.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/77\" target=\"_blank\" rel=\"noopener\">Janse F, de With LM, Duran KJ, et al. Limited contribution of NR5A1 (SF-1) mutations in women with primary ovarian insufficiency (POI). Fertil Steril 2012; 97:141.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/78\" target=\"_blank\" rel=\"noopener\">Voican A, Bachelot A, Bouligand J, et al. NR5A1 (SF-1) mutations are not a major cause of primary ovarian insufficiency. J Clin Endocrinol Metab 2013; 98:E1017.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/79\" target=\"_blank\" rel=\"noopener\">Aittom\u00e4ki K. The genetics of XX gonadal dysgenesis. Am J Hum Genet 1994; 54:844.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/80\" target=\"_blank\" rel=\"noopener\">Aittom\u00e4ki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995; 82:959.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/81\" target=\"_blank\" rel=\"noopener\">Nakamura Y, Maekawa R, Yamagata Y, et al. A novel mutation in exon8 of the follicle-stimulating hormone receptor in a woman with primary amenorrhea. Gynecol Endocrinol 2008; 24:708.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/82\" target=\"_blank\" rel=\"noopener\">Latronico AC, Anasti J, Arnhold IJ, et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996; 334:507.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/83\" target=\"_blank\" rel=\"noopener\">Levine MA, Downs RW Jr, Moses AM, et al. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 1983; 74:545.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/84\" target=\"_blank\" rel=\"noopener\">Shapiro MS, Bernheim J, Gutman A, et al. Multiple abnormalities of anterior pituitary hormone secretion in association with pseudohypoparathyroidism. J Clin Endocrinol Metab 1980; 51:483.<\/a><\/li>\n<li><a href=\"https:\/\/www.uptodate.com\/contents\/pathogenesis-and-causes-of-spontaneous-primary-ovarian-insufficiency-premature-ovarian-failure\/abstract\/85\" target=\"_blank\" rel=\"noopener\">Faull CM, Welbury RR, Paul B, Kendall-Taylor P. Pseudohypoparathyroidism: its phenotypic variability and associated disorders in a large family. Q J Med 1991; 78:251.<\/a><\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"<p>Hipogonadismul primar la femei este definit ca insuficien\u021b\u0103 ovarian\u0103 \u00eenso\u021bit\u0103 de concentra\u021bii serice ridicate de hormon foliculostimulator (FSH). Insuficien\u021ba ovarian\u0103 prematur\u0103 (POF), denumit\u0103 \u00een prezent insuficien\u021b\u0103 ovarian\u0103 primar\u0103 (POI), este definit\u0103 ca hipogonadism primar la o femeie cu v\u00e2rsta sub 40 de ani. POI se caracterizeaz\u0103 prin pierderea de ovocite, lipsa foliculogenezei \u0219i a produc\u021biei [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-218","post","type-post","status-publish","format-standard","hentry","category-uncategorized","entry"],"_links":{"self":[{"href":"https:\/\/doctorflaviaharadja.ro\/en\/wp-json\/wp\/v2\/posts\/218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/doctorflaviaharadja.ro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/doctorflaviaharadja.ro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/doctorflaviaharadja.ro\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/doctorflaviaharadja.ro\/en\/wp-json\/wp\/v2\/comments?post=218"}],"version-history":[{"count":1,"href":"https:\/\/doctorflaviaharadja.ro\/en\/wp-json\/wp\/v2\/posts\/218\/revisions"}],"predecessor-version":[{"id":219,"href":"https:\/\/doctorflaviaharadja.ro\/en\/wp-json\/wp\/v2\/posts\/218\/revisions\/219"}],"wp:attachment":[{"href":"https:\/\/doctorflaviaharadja.ro\/en\/wp-json\/wp\/v2\/media?parent=218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/doctorflaviaharadja.ro\/en\/wp-json\/wp\/v2\/categories?post=218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/doctorflaviaharadja.ro\/en\/wp-json\/wp\/v2\/tags?post=218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}